Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Irena Keber"'
Publikováno v:
Zdravniški Vestnik, Vol 79, Iss 2 (2010)
h e prevalence of anemia in patients with advanced heart failure is signii cant and is present in more than 50 % of this patient population. h e exact pathophysiologic mechanism of anemia in heart failure is still not known – it could be a direct c
Externí odkaz:
https://doaj.org/article/ab866e00d15f4ddfb15a38bb9ecc5f32
Publikováno v:
Zdravniški Vestnik, Vol 74, Iss 9 (2005)
Background: In Slovenia there is a lack of data regarding the return to work for patients after acute coronary syndrome (ACS) for last two decades. We evaluated how return to work is affected by several physical, sociodemographic and psychological fa
Externí odkaz:
https://doaj.org/article/a4cacbd9171c45439075c92fffdfe30a
Autor:
Mitja Lainščak, Mateja Kerbev, Alojz Horvat, Davorin Benko, Maja Klančnik Gruden, Irena Keber
Publikováno v:
Zdravniški Vestnik, Vol 73, Iss 3 (2004)
Background. In years 2000–1 European Society of Cardiology performed an »EuroHeart Failure« Survey in 24 European countries, including Slovenia. The aim of the survey was to determine the characteristics, diagnostic and therapeutic management of
Externí odkaz:
https://doaj.org/article/30bb93f2f38c45759ecf9f7b5d7428cd
Publikováno v:
Zdravniški Vestnik, Vol 72, Iss 3 (2003)
Background. Chronic heart failure is a serious condition with high morbidity and mortality. Prognosis can be improved with early diagnosis and adequate nonpharmacologic and pharmacologic treatment.Aims of the study. Aim of the study was a comparison
Externí odkaz:
https://doaj.org/article/6d90b1fd62f94c4d9a9fe4d4b85ddc4d
Publikováno v:
Pflugers Archiv : European journal of physiology. 439(Suppl 1)
The angiotensin-converting enzyme (ACE) plays by degradation of angiotensin I and bradykinin, an important role in modulations of smooth muscle proliferation and vascular tone. Typical plasma levels of ACE accompany the I/D polymorphism; however, a c
Autor:
Jaap W. Deckers, Euroaspire Investigators, David R. Wood, Dirk De Bacquer, Philippe Amouyel, Johan De Sutter, Viveca Gyberg, Irena Keber, Andrzej Pajak, Renata Cifkova, Guy De Backer, Seppo Lehto, Ian D. Graham, David Moore, Lars Rydén, Kornelia Kotseva, Zlatko Fraz, Jan Bruthans, Catriona Jennings
Publikováno v:
Global Heart; Vol 12, No 4 (2017); 315-322
Background: The EUROASPIRE (European Action on Secondary and Primary Prevention by Intervention to Reduce Events) cross-sectional surveys describe time trends in lifestyle and risk factor control among coronary patients between 1999 and 2013 in Belgi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45e1ec3a5d6e4c76bda464a3b352108
https://ruj.uj.edu.pl/xmlui/handle/item/117486
https://ruj.uj.edu.pl/xmlui/handle/item/117486
Publikováno v:
Wiener klinische Wochenschrift. 121:700-706
BACKGROUND: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is increasingly used in the diagnosis and prognostic assessment of heart failure; however, the possible influence of atrial fibrillation on BNP is still a matter of controversy. We ass
Publikováno v:
Heart and Vessels. 24:271-276
Heart failure is characterized by activation of the immune system which is strongly associated with disease severity and outcome. We sought to compare the prognostic impact of two established inflammatory markers - interleukin-6 (IL-6) and high-sensi
Publikováno v:
Thrombosis and Haemostasis. 102:314-320
SummaryHeart failure is characterised by activation of haemostasis. We sought to explore the prognostic impact of deranged haemostasis in chronic heart failure. In stable, optimally managed outpatients with chronic heart failure, baseline levels of p
Publikováno v:
International Heart Journal. 50:591-600
The impact of heart failure with preserved left ventricular ejection fraction (LVEF) on activated hemostasis is still unclear. We sought to compare the activation of hemostasis in patients with heart failure with preserved LVEF, with impaired LVEF, a